- $45.92bn
- $46.82bn
- $34.71bn
- 89
- 68
- 98
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22,589 | 20,140 | 36,484 | 41,512 | 34,714 |
Cost of Revenue | |||||
Gross Profit | 2,700 | 2,249 | 11,047 | 12,527 | 7,841 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 20,688 | 19,140 | 27,227 | 31,108 | 28,483 |
Operating Profit | 1,901 | 999 | 9,257 | 10,404 | 6,230 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,783 | 836 | 9,201 | 10,245 | 6,273 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,371 | 836 | 7,122 | 8,080 | 4,913 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,271 | 721 | 6,827 | 7,607 | 4,525 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,264 | 717 | 6,795 | 7,576 | 4,508 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.31 | 3.72 | 23.3 | 29.1 | 18 |
Dividends per Share |